What Is Cryobiology?

Cryobiology is the scientific study of the effects of low temperatures on biological systems, including proteins, cells, tissues, organs, and whole organisms. The field encompasses both the damage mechanisms that cold temperatures impose on living matter and the controlled application of cold for preservation, storage, and therapeutic purposes. Cryobiology draws on thermodynamics, cell physiology, biochemistry, and materials science to characterize how biological structures respond to temperatures below their normal physiological range, which for mammalian cells is generally below 37 degrees Celsius.

The field's foundational work traces to a 1960 paper in Science by Lovelock, Polge, and Smith, who demonstrated that glycerol could protect red blood cells and spermatozoa from freeze-thaw damage, establishing the concept of cryoprotection. The Society for Cryobiology defines the discipline as encompassing any biological material subjected to temperatures below the standard physiological range, including the study of naturally freeze-tolerant organisms such as certain insects and frogs that survive winter by allowing controlled intracellular ice formation.

Cryopreservation and Cryoprotection

Cryopreservation is the process of cooling biological material to temperatures typically below -130 degrees Celsius, at which metabolic activity and biochemical deterioration effectively cease, allowing indefinitely long storage without loss of viability. The central technical challenge is preventing the formation of intracellular ice crystals, which mechanically disrupt cell membranes and organelles upon thawing. Cryoprotective agents (CPAs), such as dimethyl sulfoxide (DMSO) and glycerol, reduce ice crystal formation by depressing the freezing point and increasing the viscosity of the intracellular medium, promoting vitrification, a glassy amorphous state, rather than crystalline ice. The PubMed-indexed foundational study on the freezing of biological systems by Mazur established the two-factor hypothesis of cryoinjury: at slow cooling rates, osmotic dehydration is the dominant stress; at fast cooling rates, intracellular ice formation predominates. Optimal cooling rates balance these two injury modes and vary with cell type, size, and membrane permeability.

Freezing Injury and Cell Survival

The physical and chemical stresses of freezing produce injury through several mechanisms operating across different temperature ranges. As extracellular ice forms, solute concentrations in the remaining liquid phase increase, exposing cells to hyperosmotic stress that drives water out of the cell and can denature proteins and disrupt lipid bilayer organization. Chilling injury, distinct from ice-mediated damage, occurs in some cell types at temperatures well above freezing when membrane phase transitions produce structural defects that impair function after rewarming. Cold shock, a rapid chilling stress, disrupts the cytoskeleton and protein-folding machinery independently of ice formation. Research supported by the National Institutes of Health on cryoprotective agent toxicity documents how the CPAs used to prevent ice damage are themselves toxic at the concentrations required, creating a trade-off that shapes protocol design for every cell type and tissue.

Thawing and Recovery

The thawing phase is equally critical to cryopreservation outcomes. Rapid rewarming generally improves survival compared to slow warming because it limits the duration of exposure to concentrated solutes and reduces the risk of recrystallization, a process in which small ice crystals present after slow cooling grow into larger and more damaging crystals during warming through the recrystallization temperature range. After thawing, CPA removal must be performed gradually to avoid osmotic shock from rapid rehydration. For complex tissues and organs, achieving uniform cooling and warming rates throughout the volume is a major engineering challenge because heat transfer rates vary with tissue geometry and composition. Vitrification protocols for whole organs remain an active research area aimed at enabling long-duration storage of transplantable kidneys, livers, and hearts.

Applications

Cryobiology has applications in a range of fields, including:

• Reproductive medicine: sperm, oocyte, and embryo banking for assisted reproduction
• Organ and tissue banking for transplantation and regenerative medicine
• Stem cell preservation for clinical therapies and research programs
• Blood banking and long-duration storage of red blood cells and platelets
• Cryosurgery: targeted destruction of tumors and abnormal tissue using liquid nitrogen